MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$15,893K Prepaid expenses andother current assets$379K Total$5,600K Operating leaseright-of-use assets$16,792K Total current assets$16,272K Restricted cash$1,993K Property and equipment,net$1,051K Accumulated depreciation$4,549K Total assets$36,108K Accumulated deficit-$433,709K Total liabilities andstockholders' (deficit)...$36,108K Total stockholders'(deficit) equity-$10,717K Additional paid-in capital$422,990K Common stock, 0.001 parvalue 200,000,000...$2K Total liabilities$46,825K Operating leaseliabilities, net of current...$25,441K Deferred revenue, net ofcurrent portion$11,862K Total currentliabilities$9,522K Operating leaseliabilities$4,818K Restructuring liability$3,266K Accrued expenses andother current...$775K Accounts payable$663K
Balance Sheet
source: myfinsight.com

Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. (LYRA)